Cover Image

Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions

Show other versions (1)

Camostat mesylate, a potent inhibitor of the human transmembrane protease, serine 2 (TMPRSS2), is currently under investigation for its effectiveness in COVID-19 patients. For its safe application, the risks of camostat mesylate to induce pharmacokinetic drug-drug interactions with co-administered d...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiß, Johanna (Author) , Bajraktari-Sylejmani, Gzona (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: 27 February 2021
In: Chemico-biological interactions
Year: 2021, Volume: 338, Pages: 1-7
ISSN:1872-7786
DOI:10.1016/j.cbi.2021.109428
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cbi.2021.109428
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0009279721000648
Get full text
Author Notes:Johanna Weiss, Gzona Bajraktari-Sylejmani, Walter Emil Haefeli
Search Result 1
Cover Image

Inhibition of multidrug resistance-associated protein 2 (MRP2) activity by the contraceptive nomegestrol acetate in HepG2 and Caco-2 cells by Tocchetti, Guillermo Nicolás (Author) , Weiß, Johanna (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Show all versions (2)

Similar Items